泰達生物(08189.HK)與中電信數智科技在醫療健康大數據應用、人工智能應用場景落地等方面建立長期戰略合作關係
格隆匯7月21日丨泰達生物(08189.HK)公吿,於2025年7月21日,集團附屬公司北京博雅全健智算科技有限公司("博雅全健")與中電信數智科技有限公司寧夏分公司("中電信")簽署戰略合作框架協議。雙方充分發揮各自資源、人才和技術優勢,在醫療健康大數據應用、人工智能應用場景落地,包括上述領域的線上線下專業化運營、渠道發展、成果轉化等方面建立長期戰略合作關係。
董事會認為,簽訂戰略合作協議,可藉助中電信在寧夏地區強大的網絡資源、算力支撐、基礎設施及數據優勢,並充分發揮博雅全健在人工智能與醫療健康融合領域的技術研發實力、科研成果轉化能力,實現資源互補與合作共贏。通過合作,博雅全健可加速AI醫療健康垂類技術研發與場景落地,進一步強化在"AI+醫療健康"領域的核心競爭力,助力公司業務規模擴大與行業影響力提升。
博雅全健聚焦人工智能和醫療健康科技的深度融合,構建了"技術研發-場景落地-產業賦能"的全鏈條運營體系。一方面,依託公司的醫療健康軟件平台,博雅全健與北京大學醫學部下屬醫院合作,深度運用各醫療細分領域數據,開發契合不同場景需求的醫療細分領域應用大模型;另一方面,通過搭建開放協作的生態平台,聯合科研院所、醫療機構及產業鏈上下游企業,在AI輔助診斷等方面持續提升技術轉化與場景落地效能。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.